News publication
Everything we hold that denteric.com published.
Every article we hold from denteric.com.
Denteric announced a $14 million Series A from the Brandon Capital-managed Biomedical Translation Fund, CSL and the University of Melbourne, to develop a vaccine for periodontal disease.
Under denteric.com ·leads this story in the feed
Denteric, a biotech spun out of an oral health research program, has raised $14 million for a gum disease vaccine, in a round led by the Biomedical Translation Fund with CSL also taking part.
Also denteric.com
Deals recorded from denteric.com's coverage. A round is listed once, however many of their articles mention it.
Companies named in denteric.com's articles, most-covered first.
| Company | What it does | Articles |
|---|---|---|
| Medical Research Commercialisation Fund | Venture fund commercialising biomedical research into medical products | 1 |
| Medical Research Commercialisation Fund (MRCF) | 1 | |
| Brandon Capital | 2 | |
| Denteric | Developing vaccine candidate targeting P. gingivalis linked to Alzheimer's | 2 |
Investors named in denteric.com's articles, most-covered first.
| Investor | What it does | Articles |
|---|---|---|
| Biomedical Translation Fund | 2 | |
| University of Melbourne | University operating the Melbourne Connect innovation precinct | 2 |
| Commonwealth | 1 | |
| CSL | Biotechnology company partnering on the Jumar Bioincubator grant | 1 |